Strategic Opportunities Llc Innoviva serves as Executive at Armata Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Strategic Opportunities Llc Innoviva has executed 6 insider transactions totaling $83.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 11, 2022 involved purchasing 7,598,814 shares valued at $16.7M.
Strategic Opportunities Llc Innoviva currently holds 29,270,476 shares of Armata Pharmaceuticals, Inc. (ARMP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Strategic Opportunities Llc Innoviva has been a net buyer of ARMP stock. They have purchased $83.1M and sold $0 worth of shares.
Strategic Opportunities Llc Innoviva's most recent insider trade was on Jul 11, 2022, when they purchased 7,598,814 shares at $2.20 per share.
Get notified when new Form 4 filings are submitted
| $2.20 |
| Discretionary |
| Feb 9, 2022 | ARMP | $18.1M | Purchase | 3,614,792 | $5.00 | Discretionary |
| Oct 29, 2021 | ARMP | $4.0M | Purchase | 1,212,122 | $3.30 | Discretionary |
| Jun 11, 2021 | ETTX | $12.5M | Purchase | 6,268,975 | $2.00 | Discretionary |
| Jan 26, 2021 | ARMP | $6.1M | Purchase | 1,867,912 | $3.25 | Discretionary |